Report overview
Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process.
This report aims to provide a comprehensive presentation of the global market for Drug Developing Platforms by Artificial Intelligence (AI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Developing Platforms by Artificial Intelligence (AI). This report contains market size and forecasts of Drug Developing Platforms by Artificial Intelligence (AI) in global, including the following market information:
Global Drug Developing Platforms by Artificial Intelligence (AI) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Drug Developing Platforms by Artificial Intelligence (AI) market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Software Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Drug Developing Platforms by Artificial Intelligence (AI) include Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, Row Analytics, Deep Genomics, Insilico Medicine, IBM and Microsoft, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drug Developing Platforms by Artificial Intelligence (AI) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Developing Platforms by Artificial Intelligence (AI) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Drug Developing Platforms by Artificial Intelligence (AI) Market Segment Percentages, by Type, 2022 (%)
Software
System
Service
Product
Others
Global Drug Developing Platforms by Artificial Intelligence (AI) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Drug Developing Platforms by Artificial Intelligence (AI) Market Segment Percentages, by Application, 2022 (%)
Generate Data and Models
Repurpose Existing Drugs
Generate Novel Drug Candidates
Validate and Optimize Drug Candidates
Design Drugs
Others
Global Drug Developing Platforms by Artificial Intelligence (AI) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Drug Developing Platforms by Artificial Intelligence (AI) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Developing Platforms by Artificial Intelligence (AI) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drug Developing Platforms by Artificial Intelligence (AI) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Antidote
Atomwise
Turbine
Cambridge Cancer Genomics
Row Analytics
Deep Genomics
Insilico Medicine
IBM
Microsoft
Google
AiCure
Calico
Iktos
GNS Healthcare
Genpact
Biovista
NuMedii
BenevolentAI
BERG
Schr?dinge
Nuritas
Exscientia
Kairntech
Concerto HealthAI (SymphonyAI)
NVIDIA Corporation
Sirenas
Standigm
Transcriptic
Cloud Pharmaceuticals
Cyclica
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Developing Platforms by Artificial Intelligence (AI), market overview.
Chapter 2: Global Drug Developing Platforms by Artificial Intelligence (AI) market size in revenue.
Chapter 3: Detailed analysis of Drug Developing Platforms by Artificial Intelligence (AI) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Developing Platforms by Artificial Intelligence (AI) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
